A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office, and health care giant Johnson & Johnson is joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.
Read the full story
here.